Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease
ISRCTN ISRCTN42132522
ClinicalTrials.gov identifier
Public title Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease
Scientific title Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease: a multi-centre randomised trial
Acronym DOC study
Serial number at source N/A
Study hypothesis 1. To identify the most effective case-finding pathway for chronic obstructive pulmonary disease (COPD). The specific health service impacts across different possible pathways for undertaking COPD case finding amongst current smokers in primary care settings will be assessed.
2. To assess the cost-effectiveness of COPD case-finding pathways. A cost-per-true-positive-case-found analysis will be undertaken and health care resource use will be incorporated.
3. To evaluate the efficiency of the ‘case finding’ pathway. Key factors to consider will be the quality of the forced expiratory volume in one second (FEV1)/forced vital capacity (FVC), mechanical peak expiratory flow rate (PEFR) measurements and wheezometer measurements (in relation to the reference standard).
4. To evaluate whether undergoing the diagnostic test(s) has an impact on smoking behaviour to inform future smoking cessation studies.
Lay summary
Ethics approval Approval from the Newcastle and North Tyneside 2 Research Ethics Committee was received on 29th July 2010 (Ref: 10/H0907/37)
Study design Multi-centre randomised trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic obstructive pulmonary disease (COPD)
Participants - inclusion criteria Current smokers aged 35 years or more who are registered with participating GP practices
Participants - exclusion criteria 1. Pregnancy
2. Recent history (within 8 weeks) of myocardial infarction, stroke, pulmonary embolism, chest/abdominal surgery or eye surgery
3. Any mental or physical condition (e.g. chest/ abdominal pain/ stress incontinence) or any other condition which means the participant is unable to undergo the case-finding tools
Anticipated start date 01/05/2011
Anticipated end date 31/07/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 600
Interventions 1. Participants will undertake lung function tests (i.e. peak flow measurement, microspirometry and post-bronchodilator spirometry), a wheeze-detecting device (i.e. wheezometer) and a case-finding questionnaire
2. Further questionnaires will be completed during the study; a screening questionnaire and a follow-up questionnaire.

All participants receive the case-finding tests, with half randomised to receive the tests straight away and the remainder will receive the tests approximately 6 months later.
Primary outcome measure(s) Effectiveness of diagnostic pathways – aim to identify the most effective pathway for use as the routine service model in primary care
Secondary outcome measure(s) 1. Cost-effectiveness of COPD case-finding pathway
2. Efficiency of COPD case-finding pathway
3. Impact on smoking behaviour
Sources of funding Department of Health (UK)-Respiratory Programme
Trial website
Publications
Contact name Mrs  Lisa  Dyson
  Address York Trials Unit
Ground Floor ARRC Building
Department of Health Sciences
University of York
Heslington
  City/town York
  Zip/Postcode YO10 5DD
  Country United Kingdom
  Email lisa.dyson@york.ac.uk
Sponsor University of York (UK)
  Address c/o Sue Final
Innovation Centre
  City/town York
  Zip/Postcode YO10 5DD
  Country United Kingdom
  Email sue.final@york.ac.uk
  Sponsor website: http://www.york.ac.uk/
Date applied 22/02/2011
Last edited 31/03/2011
Date ISRCTN assigned 31/03/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central